Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Balmes Transplantation
Balmes Transplantation
Activities:
Research & Development
X
LinkedIn
Trending Articles
Novartis' Kisqali plus ET bags FDA approval for HR+/HER2- breast cancer
The decision comes off the back of the Phase III NATALEE clinical trial, which diminished the risk of disease recurrence by 25.1%
Formulated Solutions expands aerosol production capabilities with fully automated line
The fully automated line will help serve the growing demand for pharmaceutical packaging in the US and further afield
RSSL opens 3D imaging and metrology laboratory for end-to-end research and analysis
The laboratory will offer, micro-CT, microscopy and spectroscopy services for its pharmaceutical and medical device partners
AstraZeneca opens a 'people hub' at its Macclesfield site
The energy-efficient building will offer AZ employees a collaborative space
TekniPlex Healthcare to showcase concept-to-commercialisation capabilities at MD&M Minneapolis
The company will emphasise expanded capabilities for class III implantable devices and delivery systems
Upcoming event
Boston Biotech Week
23-26 September, 2024 | Convention and exhibition | Boston, US
See all
Related Content
Research & Development
Balmes Transplantation raises €700,000 in seed funding
Balmes Transplantation has raised €700,000 in seed funding from the company's top executives, Patrick Berna (founder and CEO), Guillaume Demarne (CBDO) and from a group of angel investors
Subscribe now